🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/02/2016 46,57 47,13 46,29 46,61 -1,37% 1,80% 11.620.643
10/02/2016 47,24 48,10 47,22 47,26 +0,75% 1,86% 11.565.833
09/02/2016 46,46 47,30 46,18 46,91 +0,68% 2,40% 11.160.257
08/02/2016 46,69 47,07 45,77 46,59 -1,11% 2,78% 13.985.665
05/02/2016 46,37 47,44 46,06 47,12 +1,63% 2,98% 17.693.384
04/02/2016 47,42 47,46 45,83 46,36 -2,92% 3,44% 21.598.442
03/02/2016 47,35 47,81 46,36 47,76 -0,71% 3,08% 20.507.893
02/02/2016 47,97 48,20 47,61 48,10 -0,67% 1,21% 15.614.466
01/02/2016 48,08 48,65 47,56 48,43 +0,16% 2,26% 11.979.898
29/01/2016 47,52 48,35 47,31 48,35 +2,99% 2,19% 17.734.990
28/01/2016 48,02 48,23 46,74 46,95 -2,32% 3,10% 18.996.991
27/01/2016 48,34 49,21 47,55 48,06 -2,10% 3,43% 13.748.817
26/01/2016 48,71 49,24 48,44 49,09 +1,04% 1,65% 9.450.340
25/01/2016 49,00 49,08 48,44 48,59 -0,84% 1,32% 9.725.964
22/01/2016 49,08 49,37 48,62 49,00 +0,84% 1,54% 11.331.814
21/01/2016 48,45 48,97 47,80 48,59 +0,73% 2,42% 12.499.706
20/01/2016 47,99 48,68 47,04 48,23 -1,54% 3,42% 16.684.579
19/01/2016 49,24 49,53 48,48 48,99 +0,39% 2,13% 11.454.116
15/01/2016 48,19 48,95 47,81 48,80 -1,27% 2,38% 16.233.939
14/01/2016 48,35 49,72 48,27 49,43 +2,25% 3,00% 14.219.788
13/01/2016 49,53 49,68 48,26 48,34 -2,13% 2,85% 17.340.837
12/01/2016 49,15 49,69 48,65 49,39 +1,00% 2,12% 11.864.408
11/01/2016 48,90 49,18 48,29 48,90 +0,33% 1,81% 15.057.035
08/01/2016 50,11 50,11 48,53 48,74 -1,69% 3,16% 14.835.698
07/01/2016 49,16 49,92 49,08 49,58 -0,88% 1,71% 13.330.560
06/01/2016 50,11 50,52 49,82 50,02 -1,37% 1,41% 13.064.263
05/01/2016 50,37 51,02 50,26 50,72 +1,28% 1,52% 11.607.124
04/01/2016 49,63 50,20 49,25 50,08 -0,64% 1,92% 17.998.981
31/12/2015 50,38 50,85 50,25 50,40 -0,81% 1,19% 8.690.959
30/12/2015 50,90 51,13 50,65 50,81 -0,17% 0,94% 5.827.194